[1]
“Intravenous immunoglobulin therapy among pediatric patients: labeled and off-labeled indications”, Braz. J. Pharm. Sci., vol. 54, no. 1, p. e00008, Jun. 2018, doi: 10.1590/s2175-97902018000100008.